Australia's largest stock trading and investment forum Australia's #1 stock forum

PAR

Click for more information

3.51%

27.5¢ paradigm biopharmaceuticals limited..

It appears 51 Capital now also have muchconcern that 2x2 was not...

First 369 Last

Share
Profile

Follow
Mangoman605

1,551 Posts.

162

21/04/24

18:51

Post #: 73446153
Share

Originally posted by Mangoman605: ↑

So, still no tangible reason why 2x2 was not
included in dosing study. I have been banging
on about this for months, but was told by some
prominent posters here that it wasn’t necessary
because of 70 2x2 participants in previous trials,
plus at least 600 patients in SAS. We are told
there were 600 participants in dosing study. As
I understand it 3 different dosing arms plus
placebo. Despite Rennie promising to include
2x2 in his interview with Scott Williams in early
2021, it didn’t happen. What is the real reason
it wasn’t included. Surely a 600 person trial
allowed enough room for 2x2 inclusion. I also
would like to see the data for 1.5x2.

Expand

It appears 51 Capital now also have much
concern that 2x2 was not included in the dose
study.

PAR Price at posting: 28.5¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

There are more pages in this discussion • 106 more messages in this thread...

First 369 Last

Add PAR (ASX) to my watchlist

(20min delay)
Last 27.5¢		Change -0.010(3.51%)		Mkt cap ! $99.69M

Open	High	Low	Value	Volume
28.5¢	29.0¢	27.5¢	$61.22K	216.3K

Buyers (Bids)

No.	Vol.	Price($)
10	105525	27.5¢

Sellers (Offers)

Price($)	Vol.	No.
28.0¢	7600	7

View Market Depth

No.	Vol.	Price($)
10	106011	0.275
12	292423	0.270
8	116531	0.265
17	283382	0.260
7	66170	0.255

Price($)	Vol.	No.
0.280	7600	7
0.285	37981	9
0.290	52600	2
0.295	126570	4
0.300	177704	10

Last trade - 14.39pm 16/05/2024 (20 minute delay)


Last 28.0¢			Change -0.010 ( 1.23 %)
Open	High		Low	Volume
28.0¢	29.0¢		27.5¢	106693
Last updated 15.01pm 16/05/2024 ?

PAR (ASX) Chart